STOCK TITAN

[Form 4] Bruker Corporation Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Frank H. Laukien, President & CEO, Director and 10% owner of Bruker Corporation (BRKR), had restricted stock units vest and had 12,917 shares withheld across three dates to satisfy tax withholding: 3,422 shares on 08/09/2025 at $30.43, 4,657 shares on 08/10/2025 at $30.43, and 4,838 shares on 08/11/2025 at $30.78. The transactions are coded F, indicating company withholding rather than open-market sales.

Following the withholdings, his reported direct beneficial ownership was about 38.45 million shares (38,445,672 after the 08/11 transaction). The filing also lists indirect holdings including 1,055,639 shares by a former spouse and various family/UTMA holdings, showing structured family ownership but no additional dispositions reported.

Frank H. Laukien, Presidente e CEO, amministratore e azionista al 10% di Bruker Corporation (BRKR), ha visto maturare unità di azioni vincolate e sono state trattenute 12.917 azioni in tre date per soddisfare la ritenuta fiscale: 3.422 azioni il 08/09/2025 a $30.43, 4.657 azioni il 08/10/2025 a $30.43 e 4.838 azioni il 08/11/2025 a $30.78. Le transazioni sono codificate con F, indicando ritenuta da parte della società e non vendite sul mercato aperto.

Dopo le trattenute, la sua proprietà diretta dichiarata era di circa 38,45 milioni di azioni (38.445.672 dopo la transazione del 08/11). Il deposito elenca inoltre partecipazioni indirette, incluse 1.055.639 azioni detenute da una ex coniuge e varie partecipazioni familiari/UTMA, evidenziando una struttura di proprietà familiare senza ulteriori cessioni riportate.

Frank H. Laukien, presidente y CEO, director y propietario del 10% de Bruker Corporation (BRKR), tuvo la consolidación de unidades de acciones restringidas y se retuvieron 12.917 acciones en tres fechas para satisfacer la retención fiscal: 3.422 acciones el 08/09/2025 a $30.43, 4.657 acciones el 08/10/2025 a $30.43 y 4.838 acciones el 08/11/2025 a $30.78. Las transacciones están codificadas con F, lo que indica retención por parte de la empresa y no ventas en el mercado abierto.

Tras las retenciones, su propiedad directa declarada fue de aproximadamente 38,45 millones de acciones (38.445.672 después de la transacción del 08/11). La presentación también enumera participaciones indirectas, incluida una ex cónyuge con 1.055.639 acciones y diversas participaciones familiares/UTMA, mostrando una propiedad familiar estructurada pero sin disposiciones adicionales informadas.

Frank H. Laukien는 Bruker Corporation (BRKR)의 사장 겸 CEO이자 이사이며 지분 10% 보유자로, 제한 주식 단위가 성숙되어 세금 원천징수를 위해 총 12,917주가 세 차례에 걸쳐 원천징수되었습니다: 08/09/2025에 3,422주가 $30.43에, 08/10/2025에 4,657주가 $30.43에, 08/11/2025에 4,838주가 $30.78에 각각 원천징수되었습니다. 거래는 F 코드로 표기되어 공개 시장 매도가 아닌 회사에 의한 원천징수임을 나타냅니다.

원천징수 이후 신고된 그의 직접 보유 주식수는 약 38,450,000주(08/11 거래 후 38,445,672주)였습니다. 신고서에는 전 배우자가 보유한 1,055,639주 및 여러 가족/UTMA 보유분 등 간접 보유도 기재되어 있어 가족 단위로 구조화된 소유를 보여주지만 추가 처분은 보고되지 않았습니다.

Frank H. Laukien, président-directeur général, administrateur et détenteur de 10 % de Bruker Corporation (BRKR), a vu des unités d'actions restreintes arriver à échéance et 12 917 actions ont été retenues à trois dates pour couvrir la retenue d'impôt : 3 422 actions le 08/09/2025 à $30.43, 4 657 actions le 08/10/2025 à $30.43 et 4 838 actions le 08/11/2025 à $30.78. Les transactions sont codées F, ce qui indique une retenue par la société et non des ventes sur le marché ouvert.

Après ces retenues, sa propriété directe déclarée s'élevait à environ 38,45 millions d'actions (38.445.672 après la transaction du 08/11). Le dossier mentionne également des participations indirectes, y compris 1.055.639 actions détenues par une ex-épouse et diverses détentions familiales/UTMA, montrant une propriété familiale structurée sans autres cessions signalées.

Frank H. Laukien, President & CEO, Direktor und 10%-Eigentümer von Bruker Corporation (BRKR), hatte Restricted Stock Units, und insgesamt wurden 12.917 Aktien an drei Terminen einbehalten, um die Steuerabzüge zu erfüllen: 3.422 Aktien am 08/09/2025 zu $30.43, 4.657 Aktien am 08/10/2025 zu $30.43 und 4.838 Aktien am 08/11/2025 zu $30.78. Die Transaktionen sind mit F gekennzeichnet, was auf eine Einbehaltung durch das Unternehmen und nicht auf Verkäufe am offenen Markt hinweist.

Nach den Einbehaltungen belief sich sein gemeldeter direkter Besitz auf etwa 38,45 Millionen Aktien (38.445.672 nach der Transaktion am 08/11). Die Meldung führt außerdem indirekte Bestände auf, darunter 1.055.639 Aktien einer Ex-Ehefrau sowie verschiedene Familien-/UTMA-Beteiligungen, was auf eine strukturierte Familienhaltung hinweist, ohne dass weitere Veräußerungen gemeldet wurden.

Positive
  • Insider complied with tax withholding via share retention on RSU vesting, showing administrative adherence to compensation plan terms.
Negative
  • None.

Insights

TL;DR: Routine tax-withholding on vested RSUs; small, non-material reduction in direct holdings.

The Form 4 shows three F-coded transactions where 12,917 shares were withheld to cover taxes on vested restricted stock units. These withholdings are administrative and not open-market sales, leaving the reporting person with roughly 38.45 million direct shares. For most investors, this activity is immaterial to company valuation or control.

TL;DR: Filing indicates compliance and transparency; no governance change or dilution signal.

The reporting person is identified as President & CEO, Director and a >10% owner, and the filing documents tax-related withholding rather than discretionary selling. The presence of indirect family and UTMA holdings is disclosed, supporting transparency around beneficial ownership structure. No departures, sales to third parties, or changes in control are reported.

Frank H. Laukien, Presidente e CEO, amministratore e azionista al 10% di Bruker Corporation (BRKR), ha visto maturare unità di azioni vincolate e sono state trattenute 12.917 azioni in tre date per soddisfare la ritenuta fiscale: 3.422 azioni il 08/09/2025 a $30.43, 4.657 azioni il 08/10/2025 a $30.43 e 4.838 azioni il 08/11/2025 a $30.78. Le transazioni sono codificate con F, indicando ritenuta da parte della società e non vendite sul mercato aperto.

Dopo le trattenute, la sua proprietà diretta dichiarata era di circa 38,45 milioni di azioni (38.445.672 dopo la transazione del 08/11). Il deposito elenca inoltre partecipazioni indirette, incluse 1.055.639 azioni detenute da una ex coniuge e varie partecipazioni familiari/UTMA, evidenziando una struttura di proprietà familiare senza ulteriori cessioni riportate.

Frank H. Laukien, presidente y CEO, director y propietario del 10% de Bruker Corporation (BRKR), tuvo la consolidación de unidades de acciones restringidas y se retuvieron 12.917 acciones en tres fechas para satisfacer la retención fiscal: 3.422 acciones el 08/09/2025 a $30.43, 4.657 acciones el 08/10/2025 a $30.43 y 4.838 acciones el 08/11/2025 a $30.78. Las transacciones están codificadas con F, lo que indica retención por parte de la empresa y no ventas en el mercado abierto.

Tras las retenciones, su propiedad directa declarada fue de aproximadamente 38,45 millones de acciones (38.445.672 después de la transacción del 08/11). La presentación también enumera participaciones indirectas, incluida una ex cónyuge con 1.055.639 acciones y diversas participaciones familiares/UTMA, mostrando una propiedad familiar estructurada pero sin disposiciones adicionales informadas.

Frank H. Laukien는 Bruker Corporation (BRKR)의 사장 겸 CEO이자 이사이며 지분 10% 보유자로, 제한 주식 단위가 성숙되어 세금 원천징수를 위해 총 12,917주가 세 차례에 걸쳐 원천징수되었습니다: 08/09/2025에 3,422주가 $30.43에, 08/10/2025에 4,657주가 $30.43에, 08/11/2025에 4,838주가 $30.78에 각각 원천징수되었습니다. 거래는 F 코드로 표기되어 공개 시장 매도가 아닌 회사에 의한 원천징수임을 나타냅니다.

원천징수 이후 신고된 그의 직접 보유 주식수는 약 38,450,000주(08/11 거래 후 38,445,672주)였습니다. 신고서에는 전 배우자가 보유한 1,055,639주 및 여러 가족/UTMA 보유분 등 간접 보유도 기재되어 있어 가족 단위로 구조화된 소유를 보여주지만 추가 처분은 보고되지 않았습니다.

Frank H. Laukien, président-directeur général, administrateur et détenteur de 10 % de Bruker Corporation (BRKR), a vu des unités d'actions restreintes arriver à échéance et 12 917 actions ont été retenues à trois dates pour couvrir la retenue d'impôt : 3 422 actions le 08/09/2025 à $30.43, 4 657 actions le 08/10/2025 à $30.43 et 4 838 actions le 08/11/2025 à $30.78. Les transactions sont codées F, ce qui indique une retenue par la société et non des ventes sur le marché ouvert.

Après ces retenues, sa propriété directe déclarée s'élevait à environ 38,45 millions d'actions (38.445.672 après la transaction du 08/11). Le dossier mentionne également des participations indirectes, y compris 1.055.639 actions détenues par une ex-épouse et diverses détentions familiales/UTMA, montrant une propriété familiale structurée sans autres cessions signalées.

Frank H. Laukien, President & CEO, Direktor und 10%-Eigentümer von Bruker Corporation (BRKR), hatte Restricted Stock Units, und insgesamt wurden 12.917 Aktien an drei Terminen einbehalten, um die Steuerabzüge zu erfüllen: 3.422 Aktien am 08/09/2025 zu $30.43, 4.657 Aktien am 08/10/2025 zu $30.43 und 4.838 Aktien am 08/11/2025 zu $30.78. Die Transaktionen sind mit F gekennzeichnet, was auf eine Einbehaltung durch das Unternehmen und nicht auf Verkäufe am offenen Markt hinweist.

Nach den Einbehaltungen belief sich sein gemeldeter direkter Besitz auf etwa 38,45 Millionen Aktien (38.445.672 nach der Transaktion am 08/11). Die Meldung führt außerdem indirekte Bestände auf, darunter 1.055.639 Aktien einer Ex-Ehefrau sowie verschiedene Familien-/UTMA-Beteiligungen, was auf eine strukturierte Familienhaltung hinweist, ohne dass weitere Veräußerungen gemeldet wurden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LAUKIEN FRANK H

(Last) (First) (Middle)
C/O BRUKER CORPORATION
40 MANNING ROAD

(Street)
BILLERICA MA 01821

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BRUKER CORP [ BRKR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
PRESIDENT & CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/09/2025 F 3,422(1) D $30.43 38,455,167 D
Common Stock 08/10/2025 F 4,657(1) D $30.43 38,450,510 D
Common Stock 08/11/2025 F 4,838(1) D $30.78 38,445,672 D
Common Stock 1,055,639 I By Former Spouse
Common Stock 337,087 I By Son
Common Stock 336,607 I By Daughter
Common Stock 201,702 I As UTMA Custodian for Son
Common Stock 71,728 I As UTMA Custodian for Son
Common Stock 1,043 I By Former Spouse
Common Stock 272 I By Son
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person.
/s/ Michael A. Simone, Attorney-in-Fact 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Frank H. Laukien report on Form 4 for BRKR?

The filing reports tax-withholding on vested RSUs totaling 12,917 shares across three dates: 3,422 shares on 08/09/2025 at $30.43; 4,657 shares on 08/10/2025 at $30.43; 4,838 shares on 08/11/2025 at $30.78.

Why were the shares withheld according to the Form 4?

The explanation states the shares were withheld by the company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.

How many shares does Laukien beneficially own after these transactions?

Following the 08/11/2025 transaction, the reporting person’s direct beneficial ownership is reported as 38,445,672 shares. The filing also lists indirect holdings such as 1,055,639 shares by a former spouse and additional family/UTMA holdings.

Do these Form 4 entries represent open-market sales?

No. The transactions are coded F, indicating shares were withheld by the company for tax purposes rather than sold in the open market.

What roles and ownership status are disclosed for the reporting person on this Form 4?

The form identifies Frank H. Laukien as President & CEO, a Director, and a 10% owner of Bruker Corporation (BRKR).
Bruker Corp

NASDAQ:BRKR

BRKR Rankings

BRKR Latest News

BRKR Latest SEC Filings

BRKR Stock Data

4.91B
103.25M
31.97%
82.57%
6.24%
Medical Devices
Laboratory Analytical Instruments
Link
United States
BILLERICA